ALT
Altimmune Appoints Raymond Jordt as Chief Business Officer
Wednesday, January 4, 2023 BiopharmaWatch Research 1 min read Key Takeaway: Altimmune Appoints Raymond Jordt as Chief Business Officer
Price reaction · baseline $15.63 (2023-01-03 close) · hit after-hours · clean, no other ALT news in the window
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+22%
120-day peak, hindsight
Typical move
10.2%
average across 8 past catalysts
Cash runway
~64 mo
Minimal dilution risk
Lead asset
ALT-801
Phase 2 · Obesity/Overweight
Full Press Release Details
Altimmune Appoints Raymond Jordt as Chief Business Officer.